Intellicure Analytics Logo

Global Perspective on Investments and Acquisitions in Wound Care and Regenerative Medicine

Jul 20, 2026

ProDevLabs provides an indepth look at the CAMPS reset in wound care and the convergence with regenerative medicine in 2025-2026.
Get ready for SmartTRAK In2Data 2026! Before joining us as a guest panelist at the Gaylord Texan Resort on November 4, Mitch Sanders, PhD, CEO of ProDevLabs, shares his insights in this exclusive guest post. Click here for event details and early-bird pricing, then read on for his expert perspective.
Approximately $800MM was invested across wound care and regenerative medicine during 2025-2026, withSolventum’s$850MM acquisition ofAcera Surgical, post its spin-off from 3M, the most significant strategic activity of the year. Acera Surgical commercializes RESTRATA– a synthetic electrospun fiber matrix for advanced wound care applications, with sales projected at $90MM in 2025. Read More